Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07428980 · ClinicalTrials.gov registry record · NA
Noninvasive Brain Stimulation to Enhance Cognition at Home Following a TBI.
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT07428980: Completed NA study, sponsored by Shirley Ryan AbilityLab.
NCT07428980 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07428980, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous vagus nerve stimulation (tVNS) at home, to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).
Primary Outcome
Recording the number of participant who completed at least 75% of the sessions out of the number of participants enrolled in the study.
Interventions
- DEVICE Transcutaneous Vagus Nerve Stimulation (tVNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2026-01-09 |
| Est. Completion | 2026-04-27 |
| Phase | NA |
What the finished NCT07428980 record still lists
NCT07428980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous Vagus Nerve Stimulation (tVNS) is the first listed.
NCT07428980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07428980 about?
NCT07428980 is a clinical study titled "Noninvasive Brain Stimulation to Enhance Cognition at Home Following a TBI.". The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous vagus nerve stimulation (tVNS) at home, to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).
What is the current status of trial NCT07428980?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2026-01-09. Estimated completion is 2026-04-27.
What interventions are being tested in trial NCT07428980?
The interventions under investigation include: Transcutaneous Vagus Nerve Stimulation (tVNS) (DEVICE).
Who is sponsoring clinical trial NCT07428980?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07428980's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI